Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02276820Phase 1Withdrawn
Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)
Adenovirus Infection
PrincipalinvestigatorStart date: 2017-12-07
NCT01447056Phase 1Completed
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases
Hodgkin LymphomaLeiomyosarcomaLymphoproliferative Disorder+3 more
PrincipalinvestigatorStart date: 2012-02-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinHodgkin DiseaseAdenoviridae Infections+1 more

Worked with same sponsors:

AlloVirBaylor College of Medicine+2 more
Similarity Score17%

Swati Naik, MD

Baylor College of Medicine

Related
1 trials

Shared therapeutic areas:

Adenoviridae Infections

Worked with same sponsors:

AlloVirBaylor College of Medicine+2 more
Collaborated on 1 trial
Similarity Score14%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoproliferative DisordersLymphoma, Non-Hodgkin
Similarity Score13%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinHodgkin DiseaseLymphoproliferative Disorders

Worked with same sponsors:

Baylor College of Medicine
Similarity Score13%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinNasopharyngeal Carcinoma
Similarity Score9%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score9%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score9%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score9%

Pier Luigi Zinzani, MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Related
14 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score9%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Nasopharyngeal Carcinoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02276820Phase 1PrincipalInvestigator

Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A)

Adenovirus Infection
Withdrawn
NCT01447056Phase 1PrincipalInvestigator

Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Hodgkin LymphomaLeiomyosarcomaLymphoproliferative Disorder+3 more
Completed

All 2 trials loaded